Authors: Felipe J. Núñez, Flor Mendez, Padma Kadiyala, Mahmoud S. Alghamri, Masha G. Savelieff, María Belén Garcia-Fabiani, Santiago Haase, Carl Koschmann, Anda‐Alexandra Calinescu, Neha Kamran, Meghna Saxena, Rohin Patel, Stephen V. Carney, Marissa Guo, Marta Edwards, Mats Ljungman, Tingting Qin, Maureen A. Sartor, Rebecca Tagett, Sriram Venneti, Jacqueline A. Brosnan‐Cashman, Alan K. Meeker, Vera Gorbunova, Lili Zhao, Daniel M. Kremer, Li Zhang, Costas A. Lyssiotis, Lindsey Jones, Cameron J. Herting, James Ross, Dolores Hambardzumyan, Shawn L. Hervey‐Jumper, María E. Figueroa, Pedro R. Löwenstein, Maria G. Castro - Science Translational Medicine 2019 cited by 290
glioma harboring TP53 and ATRX loss could improve the therapeutic efficacy of radiotherapy and, consequently, patient survival.
